Mackay Shields LLC Immuno Gen, Inc. Transaction History

Mackay Shields LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$1.8 - $3.3 $118,998 - $218,163	-66,110 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $40,621 - $100,006	10,310 Added 18.48%	66,110 $317,000
Q3 2018 Nov 14, 2018	BUY	$8.6 - $11.26 $86,860 - $113,726	10,100 Added 22.1%	55,800 $528,000
Q2 2018 Aug 06, 2018	BUY	$9.52 - $12.15 $435,064 - $555,255	45,700 New	45,700 $445,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.